Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › LA › Leesville › NPI 1881665164
Hospital

Clhg-Leesville

Clhg-Leesville was paid $16.30M by Medicaid between Jan 2018 and Dec 2024, across 209 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.

33Billing provider infoCLHG-LEESVILLE
LEESVILLE, LA 71446
33aNPI1881665164assigned 01/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.30M
24GClaims360,084
24DCodes billed209
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Louisiana

Rank by total paid#26 of 96
Median peer was paid$5.17M
This provider vs. median3.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201829,929$1.17M
201929,248$924K
202025,791$873K
202151,465$2.21M
202278,255$3.32M
202378,146$4.05M
2024incomplete67,250$3.75M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 23% 20,480 18,523 $3.76M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 9,659 8,552 $2.48M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 20,004 18,360 $2.26M
74176 Computed tomography, abdomen and pelvis; without contrast material 7.6% 1,643 1,458 $1.25M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.3% 743 678 $701K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4.1% 11,238 9,462 $675K
70450 Computed tomography, head or brain; without contrast material 3.3% 1,675 1,473 $532K
71045 Radiologic examination, chest; single view 2.5% 9,674 8,515 $405K
58662 2.4% 791 514 $394K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 1.5% 2,220 1,856 $247K
87428 1.5% 8,345 7,533 $246K
G0378 Hospital observation service, per hour 1.5% 915 713 $246K
197 more codes
80053 Comprehensive metabolic panel 1.3% 30,164 $217K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.1% 33,994 $180K
80050 General health panel 1.0% 4,049 $164K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 421 $150K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,461 $134K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,238 $100K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 332 $82K
93017 <1% 289 $81K
80061 Lipid panel <1% 6,538 $77K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 719 $74K
94060 <1% 269 $69K
59025 Fetal non-stress test <1% 505 $64K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 998 $59K
84484 <1% 7,637 $55K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 998 $50K
83880 <1% 2,347 $49K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 738 $49K
71046 Radiologic examination, chest; 2 views <1% 1,073 $48K
88312 <1% 1,390 $46K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,373 $42K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,000 $42K
81001 <1% 18,644 $42K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,276 $39K
83036 Hemoglobin; glycosylated (A1C) <1% 4,527 $39K
96361 Intravenous infusion, hydration; each additional hour <1% 923 $38K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 652 $38K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,525 $37K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 64 $36K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,199 $36K
96375 Therapeutic injection; each additional sequential IV push <1% 1,024 $36K
81025 <1% 4,867 $34K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,013 $30K
36415 Collection of venous blood by venipuncture <1% 16,498 $29K
88142 <1% 1,630 $29K
84439 <1% 3,710 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 142 $26K
82553 <1% 4,388 $26K
94729 <1% 300 $24K
94726 <1% 291 $23K
85730 <1% 6,038 $23K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,511 $21K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 835 $21K
82550 <1% 5,293 $20K
83735 <1% 4,489 $20K
83690 <1% 3,838 $20K
93880 <1% 117 $19K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 525 $19K
73562 <1% 205 $19K
83721 <1% 2,584 $18K
93970 <1% 77 $18K
85610 <1% 6,503 $17K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 2,663 $17K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 754 $16K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,136 $15K
72110 <1% 143 $15K
93976 <1% 610 $15K
84443 Thyroid stimulating hormone (TSH) <1% 987 $14K
81514 <1% 70 $14K
93925 <1% 46 $12K
88112 <1% 469 $11K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 365 $11K
64721 <1% 40 $11K
73630 <1% 183 $10K
73130 <1% 205 $9K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 212 $9K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 19 $9K
72141 <1% 16 $9K
94664 <1% 270 $9K
C1760 Closure device, vascular (implantable/insertable) <1% 90 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 33 $8K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 49 $8K
87807 <1% 649 $7K
29880 <1% 13 $7K
72125 Computed tomography, cervical spine; without contrast material <1% 13 $7K
76830 Ultrasound, transvaginal <1% 73 $7K
99213 Doctor's office visit, returning patient (routine) <1% 397 $7K
49322 <1% 43 $7K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 387 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 68 $7K
82746 <1% 530 $7K
87040 <1% 999 $6K
80074 <1% 158 $6K
82607 <1% 501 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 119 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 1,374 $5K
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 520 $5K
85576 <1% 741 $5K
85027 <1% 818 $5K
94618 <1% 86 $4K
72050 <1% 45 $4K
71250 <1% 14 $4K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 48 $4K
93015 <1% 14 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,153 $3K
45384 <1% 12 $3K
87400 <1% 271 $3K
84703 <1% 353 $3K
73030 <1% 41 $3K
72084 <1% 14 $3K
87088 <1% 359 $3K
86592 <1% 694 $3K
84702 <1% 255 $3K
86140 <1% 589 $3K
96376 <1% 82 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,810 $2K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 13 $2K
82150 <1% 419 $2K
73560 <1% 41 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 184 $2K
76000 <1% 284 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 19 $2K
85379 <1% 282 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 26 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 13 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 69 $2K
86850 <1% 476 $2K
83874 <1% 194 $2K
87186 <1% 274 $2K
87077 <1% 680 $2K
86787 <1% 145 $2K
83605 <1% 261 $2K
87529 <1% 38 $1K
73110 <1% 43 $1K
85652 <1% 609 $1K
82728 <1% 114 $1K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 71 $1K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 44 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 299 $1K
86900 <1% 530 $1K
73564 <1% 15 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 521 $1K
84100 <1% 384 $982.84
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 15 $975.00
83550 <1% 134 $945.77
86901 <1% 431 $887.95
84481 <1% 69 $874.19
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 1,202 $815.87
94760 <1% 55 $811.62
87797 <1% 31 $791.41
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 20 $788.31
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 31 $763.80
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,031 $749.93
J7120 Ringers lactate infusion, up to 1000 cc <1% 509 $704.92
83540 <1% 134 $700.15
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 31 $687.18
80069 <1% 83 $659.55
84134 <1% 102 $619.33
86703 <1% 43 $560.43
82677 <1% 26 $551.44
80305 <1% 47 $511.48
J0690 Injection, cefazolin sodium, 500 mg <1% 2,639 $503.41
73090 <1% 14 $479.10
85018 <1% 265 $417.79
J0153 Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) <1% 31 $415.40
J2704 Injection, propofol, 10 mg <1% 7,067 $388.75
82105 <1% 26 $382.45
86336 <1% 26 $355.54
86762 <1% 29 $346.99
84403 <1% 13 $283.91
84402 <1% 13 $280.17
J1170 Injection, hydromorphone, up to 4 mg <1% 529 $269.47
84270 <1% 13 $239.03
87340 <1% 28 $238.77
88304 <1% 755 $212.46
85378 <1% 43 $200.46
84153 <1% 12 $185.74
C9113 Injection, pantoprazole sodium, per vial <1% 21 $183.26
87481 <1% 67 $182.47
87081 <1% 29 $179.01
86738 <1% 13 $161.52
83655 <1% 14 $158.64
90961 <1% 12 $156.58
80320 <1% 13 $156.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 100 $148.21
82950 <1% 33 $138.26
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,314 $137.67
87070 <1% 19 $137.41
86039 <1% 14 $136.16
76937 <1% 85 $113.11
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 4,848 $84.11
82948 <1% 47 $77.58
84550 <1% 28 $76.84
82043 <1% 17 $57.80
82947 <1% 18 $55.41
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 139 $52.11
82570 <1% 17 $51.80
82610 <1% 12 $50.48
J2550 Injection, promethazine hcl, up to 50 mg <1% 45 $39.20
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 414 $38.78
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,093 $35.68
J1030 Injection, methylprednisolone acetate, 40 mg <1% 322 $27.09
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 411 $13.49
J2060 Injection, lorazepam, 2 mg <1% 16 $7.05
74420 0% 31 $0.00
00000 0% 30 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 54 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 52 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialQUINN, KEVIN (CEO)
Same official

Other billing entities under QUINN, KEVIN

Full network →
ProviderLocationPaid
Clhg-Leesville LLCLeesville, LA$32K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.